Yuksel Urun (Yüksel Ürün)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 35

Top Topics

Drug Administration

Renal Cell Carcinoma

Prostate Cancer

Top Venues

Future oncology (London, England)

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Efe Cem Erdat, Merih Yalciner, Yuksel Urun
Accuracy and usability of artificial intelligence chatbot generated chemotherapy protocols. Future oncology (London, England) (2024)
Beliz Bahar Karaoğlan, Yuksel Urun
Unveiling the Role of Human Papillomavirus in Urogenital Carcinogenesis a Comprehensive Review. Viruses 16 (5) (2024)
Beliz Bahar Karaoğlan, Yuksel Urun
Unveiling the Role of Human Papillomavirus in Urogenital Carcinogenesis a Comprehensive Review. Viruses 16 (5) (2024)
Beliz Bahar Karaoğlan, Berna Savaş, Gungor Utkan, Yuksel Urun
Exploring the connection between microsatellite instability and inflammatory indicators in cancers. Future oncology (London, England) (2024)
Beliz Bahar Karaoğlan, Berna Savaş, Gungor Utkan, Yuksel Urun
Exploring the connection between microsatellite instability and inflammatory indicators in cancers. Future oncology (London, England) 20 (2) (2024)
Hatice Bolek, Cagatay Arslan, Mert Basaran, Irfan Cicin, Mustafa Özgüroğlu, Deniz Tural, Yuksel Urun
Perceptions and Expectations: A Study on Prognostic Perception and Quality of Life in Patients With Metastatic Renal and Bladder Cancer. JCO global oncology 10 (2024)
Beliz Bahar Karaoğlan, Berna Savaş, Gungor Utkan, Yuksel Urun
Exploring the connection between microsatellite instability and inflammatory indicators in cancers. Future oncology (London, England) 20 (2) (2024)
Beliz Bahar Karaoğlan, Emre Yekedüz, Satı Coşkun Yazgan, Eda Eylemer Mocan, Elif Berna Koksoy, Hatime Arzu Yasar, Filiz Çay Şenler, Gungor Utkan, Ahmet Demirkazık, Hakan Akbulut, Yuksel Urun
Impact of low sodium values on survival outcomes of patients with cancer receiving immune checkpoint inhibitors. Immunotherapy (2024)
Efe Cem Erdat, Merih Yalciner, Yuksel Urun
Accuracy and usability of artificial intelligence chatbot generated chemotherapy protocols. Future oncology (London, England) (2024)
Beliz Bahar Karaoğlan, Yuksel Urun
Unveiling the Role of Human Papillomavirus in Urogenital Carcinogenesis a Comprehensive Review. Viruses 16 (5) (2024)
Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kılıçkap
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study. Cancer medicine (2023)
Hatice Bolek, Yuksel Urun
Cancer-associated thrombosis and drug-drug interactions of antithrombotic and antineoplastic agents. Cancer (2023)
Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kılıçkap
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study. Cancer medicine (2023)
Ender Kalaci, Yuksel Urun
Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kılıçkap
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study. Cancer medicine 13 (1) (2023)
İlgın Akbıyık, Yuksel Urun
Determining magnitude of benefit from poly(ADP-ribose) polymerase inhibitors in prostate cancer. Future oncology (London, England) (2023)
Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kılıçkap
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study. Cancer medicine (2023)
Emre Yekedüz, Elif Gizem Aktaş, Elif Berna Koksoy, Neslihan Doğan, Yuksel Urun, Gungor Utkan
The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib. Future oncology (London, England) 18 (9) (2022)
Satı Coşkun Yazgan, Emre Yekedüz, Güngör Utkan, Yuksel Urun
Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitors. The Prostate 82 (15) (2022)
Emre Yekedüz, Güngör Utkan, Yuksel Urun
Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors. Future oncology (London, England) 18 (4) (2022)
Emre Yekedüz, Deniz Tural, İsmail Ertürk, Serdar Karakaya, Cihan Erol, Özlem Ercelep, Çağatay Arslan, Özlem Nuray Sever, Saadettin Kılıçkap, Nihan Şentürk Öztaş, Ahmet Küçükarda, Orçun Can, Berna Öksüzoğlu, Mehmet Ali Şendur, Nuri Karadurmuş, Yuksel Urun
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study. Journal of cancer research and clinical oncology 148 (12) (2022)
Nobuaki Matsubara, Johann S de Bono, David Olmos, Giuseppe Procopio, Satoru Kawakami, Yuksel Urun, Robbert van Alphen, Aude Flechon, Michael A Carducci, Young Deuk Choi, Sebastien J Hotte, Ernesto Korbenfeld, Gero Kramer, Archana M Agarwal, Kim N Chi, Simon Dearden, Christopher Gresty, Jinyu Kang, Christian Poehlein, Elizabeth A Harrington, Maha H A Hussain
Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1, BRCA2 or ATM Alterations Identified by Testing Circulating Tumor DNA. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Emre Yekedüz, Dario Trapani, Wenxin Xu, Elisabeth G E de Vries, Chris Labaki, Bishal Gyawali, Shuchi Gulati, Chadi Nabhan, Güngör Utkan, Giuseppe Curigliano, Toni K Choueiri, Yuksel Urun
Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors. International journal of cancer 149 (7) (2021)
Emre Yekedüz, İsmail Ertürk, Deniz Tural, Nuri Karadurmus, Serdar Karakaya, Mutlu Hizal, Rukiye Arıkan, Çağatay Arslan, Hakan Taban, Ahmet Küçükarda, Nihan Şentürk Öztaş, Ozlem Nuray Sever, Gokhan Ucar, Orçun Can, Mehmet Ali Nahit Şendur, Umut Demirci, Saadettin Kılıçkap, Irfan Cicin, Ömür Berna Çakmak Öksüzoğlu, Mustafa Özgüroğlu, Yuksel Urun
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database. Future oncology (London, England) 17 (35) (2021)
Emre Yekedüz, Güngör Utkan, Yuksel Urun
Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle? Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (2) (2021)
Emre Yekedüz, Ruveyda Ayasun, Elif Berna Koksoy, Gungor Utkan, Yuksel Urun, Hakan Akbulut
mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors. Future virology (2021)
Emre Yekedüz, Hatime Arzu Yasar, Güngör Utkan, Yuksel Urun
A systematic review: Role of systemic therapy on treatment and prevention of brain metastasis in renal cell carcinoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (4) (2020)
Gökce Kenar, Elif Berna Koksoy, Yuksel Urun, Gungor Utkan
Prevalence, etiology and risk factors of anemia in patients with newly diagnosed cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 28 (11) (2020)
Hatime Arzu Yasar, Erman Akkus, Aylin Heper, Bengu N Akay, Yuksel Urun, Gungor Utkan
Sweet's syndrome under ipilimumab therapy and a brief comparison of the cases in literature. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (7) (2020)
Mutlu Hizal, Mehmet An Sendur, Hatime Arzu Yasar, Kadriye Bir Yucel, Cagatay Arslan, Gokhan Ucar, Serdar Karakaya, Hakan Taban, Ahmet Kucukarda, Ismail Erturk, Burak Bilgin, Nuriye Yıldırım, Umut Demirci, Saadettin Kılıckap, Irfan Cicin, Nuri Karadurmus, Bulent Yalcin, Yuksel Urun
Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study). Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (7) (2020)
Emre Yekedüz, Bengü Dursun, Güle Ç Aydın, Satı C Yazgan, Halis H Öztürk, Alpay Azap, Güngör Utkan, Yuksel Urun
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (5) (2020)
Emre Yekedüz, Ayşe Müge Karcıoğlu, Gungor Utkan, Yuksel Urun
A clinical dilemma amid COVID-19 pandemic: missed or encountered diagnosis of cancer? Future oncology (London, England) 16 (25) (2020)
Emre Yekedüz, Elif Berna Koksoy, Hakan Akbulut, Yuksel Urun, Gungor Utkan
ctDNA as a prognostic factor in operable colon cancer patients: a systematic review and meta-analysis. Future oncology (London, England) 17 (3) (2020)
Hatime Arzu Yasar, Kadriye Bir Yucel, Cagatay Arslan, Gokhan Ucar, Serdar Karakaya, Burak Bilgin, Hakan Taban, Ahmet Kucukarda, Ismail Erturk, Mutlu Hızal, Birol Yıldız, Nuriye Yıldırım, Umut Demirci, Mehmet Ali Sendur, Gungor Utkan, Saadettin Kılıckap, Irfan Cicin, Nuri Karadurmus, Yuksel Urun
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (5) (2019)
Yuksel Urun, Hatime Arzu Yasar, Hande Turna, Saadettin Kılıçkap, Ahmet Sezer, Berna Öksüzoğlu, Nuriye Özdemir, Ma Nahit Şendur, Hüseyin Abalı
Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter? Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (8) (2019)